Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Where to inject B12 Where you self-inject B12 is a matter of personal choice
Elderly patients with limited dexterity: Older adults with arthritis, neuropathy, or tremors may struggle with the fine motor skills needed for injection preparation and administration
25 mg/day oral Tirzepatide 15 mg/week Retatrutide 12 mg/week Liraglutide 3.0 mg/day Factor Peak trial weight loss Semaglutide -14.9% at 68 wks (STEP 1) Tirzepatide -22.5% at 72 wks (SURMOUNT-1) Retatrutide -28.7% at 68 wks (TRIUMPH-4) Liraglutide -8% at 56 wks (SCALE) Factor FDA status (June 2026) Semaglutide Approved (T2D, obesity, CVD, MASH, CKD, oral) Tirzepatide Approved (T2D, obesity) Retatrutide Investigational - Phase 3 Liraglutide Approved (Saxenda obesity, Victoza T2D) Factor CV outcomes data Semaglutide Yes - SELECT (20% MACE drop) Tirzepatide SURPASS-CVOT ongoing Retatrutide TRIUMPH-3 ongoing Liraglutide Yes - LEADER (13% MACE drop) These compounds are not interchangeable
Neither directly affects UTI risk, but both require monitoring that should include kidney function tests, which can incidentally identify early urinary tract issues
Dysbiosis and Genomic Plasticity in the Oily Scalp Microbiome: A Multi-omics Analysis of Dandruff Pathogenesis
If your employer uses a self-funded plan administered by UHC, the formulary decisions are made by your employers benefits team, not by UnitedHealthcare
